Co-Authors
This is a "connection" page, showing publications co-authored by Konstantinos Tsioufis and Michael Doumas.
Connection Strength
1.238
-
Renal Sympathetic Denervation in Isolated Systolic Hypertension. Hypertension. 2019 08; 74(2):255-256.
Score: 0.828
-
Time in Therapeutic Range, as a Determinant of All-Cause Mortality in Patients With Hypertension. J Am Heart Assoc. 2017 Nov 03; 6(11).
Score: 0.185
-
The Co-Existence of NASH and Chronic Kidney Disease Boosts Cardiovascular Risk: Are there any Common Therapeutic Options? Curr Vasc Pharmacol. 2018; 16(3):254-268.
Score: 0.047
-
Effect of renal sympathetic denervation on short-term blood pressure variability in resistant hypertension: a meta-analysis. J Hypertens. 2017 09; 35(9):1750-1757.
Score: 0.046
-
Renal Denervation Therapy for Drug-Resistant Hypertension: Does It Still Work? Curr Treat Options Cardiovasc Med. 2017 May; 19(5):39.
Score: 0.045
-
The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement. Metabolism. 2017 06; 71:17-32.
Score: 0.044
-
Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment: The Action to Control Cardiovascular Risk in Diabetes Study. Am J Nephrol. 2017; 45(2):136-145.
Score: 0.044